Ernesta Cavalcanti - Concepedia

Author

Ernesta Cavalcanti

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"ORCID

Also Known As

Antonella Petrillo, Cavalcanti, Ernesta, E Cavalcanti, E. Cavalcanti, ERNESTA CAVALCANTI, Edila Figueredo Feitosa Cavalcanti, Ellen Bethania de Oliveira Cavalcanti, Ernesta Cavalcanti

116

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"University of Naples Federico II University of Catania Istituti di Ricovero e Cura a Carattere Scientifico St. Michael's Hospital

About

Ernesta Cavalcanti is an author at Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" specializing in medicine, tumor biology, and dermatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	375
2	Health Sciences	2	2	74
3	Cell Biology	2	2	51
4	Nursing	1	1	63
5	Clinical Nutrition	1	1	63

Ernesta Cavalcanti

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab Mariaelena Capone, Diana Giannarelli, Domenico Mallardo, Journal for ImmunoTherapy of Cancer	2018	499
Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma Ester Simeone, Giusy Gentilcore, Diana Giannarelli, Cancer Immunology Immunotherapy Cancer ImmunosurveillanceMedicineBiological ChangesMelanomaImmunology	2014	250
Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1 Crescenzo D’Alterio, Maria Buoncervello, Caterina Ieranò, Journal of Experimental & Clinical Cancer Research	2019	105
Quality of Life in Women Diagnosed with Breast Cancer after a 12-Month Treatment of Lifestyle Modifications Concetta Montagnese, Giuseppe Porciello, Sara Vitale, Nutrients	2020	101
Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial Francesco Caponigro, Elena Di Gennaro, Franco Ionna, BMC Cancer	2016	63
Mediterranean diet and quality of life in women treated for breast cancer: A baseline analysis of DEDiCa multicentre trial Giuseppe Porciello, Concetta Montagnese, Anna Crispo, PLoS ONE NutritionQuality Of LifeBreast OncologyHealthy SubjectsCancer Management	2020	63
Metabolic syndrome and the risk of urothelial carcinoma of the bladder: a case-control study Maurizio Montella, Matteo Di Maso, Anna Crispo, BMC Cancer	2015	55
AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment Emilia Caputo, Roberta Miceli, Maria Letizia Motti, Journal of Translational Medicine	2014	50
Low glycemic index diet, exercise and vitamin D to reduce breast cancer recurrence (DEDiCa): design of a clinical trial Livia S. A. Augustin, Massimo Libra, Anna Crispo, BMC Cancer	2017	43
Polydatin Reduces Cardiotoxicity and Enhances the Anticancer Effects of Sunitinib by Decreasing Pro-Oxidative Stress, Pro-Inflammatory Cytokines, and NLRP3 Inflammasome Expression Vincenzo Quagliariello, Massimiliano Berretta, Simona Buccolo, Frontiers in Oncology	2021	43

Page 1